+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Protalex Inc - logo

Protalex is a clinical-stage biopharmaceutical company focused on the development of drugs for treating autoimmune and inflammatory diseases including Rheumatoid Arthritis (RA) and Immune Thrombocytopenia (ITP). Protalex’s lead product, PRTX-100, is a formulation of a proprietary, highly purified form of Staphylococcal Protein A, which is an immunomodulatory protein produced by bacteria. The company was founded in 1999 and is based in Florham Park, New Jersey.

From
From
From
Rheumatoid Arthritis - Pipeline Review, H2 2020 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 1191 pages
From
Rheumatoid Arthritis: Beyond TNF Inhibitors, 2016-2026 - Product Thumbnail Image

Rheumatoid Arthritis: Beyond TNF Inhibitors, 2016-2026

  • Report
  • November 2016
  • 240 Pages
From
From
Idiopathic Thrombocytopenic Purpura - Pipeline Review, H2 2020 - Product Thumbnail Image

Idiopathic Thrombocytopenic Purpura - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 180 pages
From
Idiopathic Thrombocytopenic Purpura - Pipeline Insight, 2020 - Product Thumbnail Image

Idiopathic Thrombocytopenic Purpura - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 pages
From
From
From
From
Myasthenia Gravis - Pipeline Review, H2 2020 - Product Thumbnail Image

Myasthenia Gravis - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 254 pages
From
From
From
From
Competitor Landscape: Spondyloarthritis - Product Thumbnail Image

Competitor Landscape: Spondyloarthritis

  • Report
  • November 2018
  • 64 pages
From
From
  • 20 Results (Page 1 of 1)
Loading Indicator
adroll